AbbVie (NYSE:ABBV) announced today that it invested $195 million to expand domestic active pharmaceutical ingredient (API) production. The company’s investment comes in its North Chicago, Illinois, plant to advance its U.S. API manufacturing. This expansion comes as part of AbbVie’s commitment to invest more than $10 billion in the U.S. to broadly support innovation and… The post AbbVie to invest $195M in U.S. active pharmaceutical ingredient manufacturing appeared first on Pharmaceutic...
